Skip to main content
Clinical Trials/NL-OMON45293
NL-OMON45293
Completed
Phase 4

Pilot study: postoperative pain reduction by pre emptive N-Acetylcysteine - NAC.TEP16

Radboud Universitair Medisch Centrum0 sites60 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Pijngeneeskunde
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 29, 2018
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • subjects ASA 1\-2 sceduled for laparoscopic inguinal hernia repair

Exclusion Criteria

  • \- Pregnancy or lactating
  • \- Allergy to NAC
  • \- History of chronic pain
  • \- Use of opioids or neuropathic analgesics
  • \- Use of NAC prior to trial (\< 1 month of planned surgery)
  • \- Alcoholism
  • \- Diabetes Mellitus
  • \- Asthma or Chronic Obstructive Pulmonary Disease
  • \- Known renal function disorders (MDRD \<60\)
  • \- Known liver failure (bilirubine \>1\.5x upper limit of normal)

Outcomes

Primary Outcomes

Not specified

Similar Trials